NOVAMETRIX MEDICAL SYSTEMS INC
DFAN14A, 1996-11-18
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Previous: NOVAMETRIX MEDICAL SYSTEMS INC, DEFA14A, 1996-11-18
Next: NOVAMETRIX MEDICAL SYSTEMS INC, DFAN14A, 1996-11-18



                          UNITED STATES
                SECURITIES AND EXCHANGE COMMISSION
                      Washington, D.C. 20549

                           SCHEDULE 14A

   Proxy Statement Pursuant to Section 14(a) of the Securities
              Exchange Act of 1934 (Amendment No. 1)

Filed by the Registrant ( )
Filed by a Party other than the Registrant (X)

Check the appropriate box:

( )  Preliminary Proxy Statement     ( )  Confidential for Use of 
                                          the Commission Only (as
( )  Definitive Proxy Statement           permitted by Rule       
                                          14a-6(e)(2))
(x)  Definitive Additional Materials
( )  Soliciting Material Pursuant to (Section)240.14a-11(c) or
     (Section)240.14a-12

_________________________________________________________________
____________
         (Name of Registrant as Specified In Its Charter)

_________________________________________________________________
______________
(Name of Person(s) Filing Proxy Statement, if other than the
Registrant)

Payment of Filing Fee (Check the appropriate box):
( )  $125 per Exchange Act Rules 0-11(c)(1)(ii), 14a-6(i)(1),     
     14a-6(i)(2)
     or item 22(a)(2) of Schedule 14A.
( )  $500 per each party to the contoversy pursuant to Exchange Act

     Rule 14a-6(i)(3).
( )  Fee computed on table below per Exchange Act Rules 14a-6(i)(4)

     and 0-11.

   1) Title of each class of securities to which transaction      
      applies:

_________________________________________________________________
____________

   2) Aggregate number of securities to which transaction applies:

_________________________________________________________________
____________

   3) Per unit price or other underlying value of transaction     
      computed pursuant to Exchange Act Rule 0-11 (Set forth the
      amount on which the filing fee is calculated and state how it
      was determined):

_________________________________________________________________
____________

   4) Proposed maximum aggregate value of transaction:

_________________________________________________________________
____________

   5) Total fee paid:

_________________________________________________________________
____________

   DEFINITIVE PROXY STATEMENT




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission